✦ LIBER ✦

An evaluation of gene–gene interaction between the CYP2C9 and VKORC1 genotypes affecting the anticoagulant effect of phenprocoumon and acenocoumarol

✍ Scribed by R. M. F. VAN SCHIE; A. M. V. BABAJEFF; T. SCHALEKAMP; J. A. M. WESSELS; S. LE CESSIE; A. de BOER; F. J. M. VAN DER MEER; E. VAN MEEGEN; T. I. VERHOEF; F. R. ROSENDAAL; A. H. MAITLAND-VAN DER ZEE; FOR THE EU-PACT STUDY GROUP

Book ID: 114754741
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 259 KB
Volume: 10
Category: Article
ISSN: 1538-7933
DOI: 10.1111/j.1538-7836.2012.04694.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

VKORC1 and CYP2C9 Genotypes and Phenproc

VKORC1 and CYP2C9 Genotypes and Phenprocoumon Anticoagulation Status: Interaction Between both Genotypes Affects Dose Requirement

✍ Schalekamp, T; Brassé, B P; Roijers, J F M; van Meegen, E; van der Meer, F J M; 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 174 KB

Long-term anticoagulant effects of the C

Long-term anticoagulant effects of the CYP2C9 and VKORC1 genotypes in acenocoumarol users

✍ T. I. VERHOEF; W. K. REDEKOP; M. M. BUIKEMA; T. SCHALEKAMP; F. J. M. VAN DER MEE 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 292 KB

Genotypes Associated With Reduced Activi

Genotypes Associated With Reduced Activity of VKORC1 and CYP2C9 and Their Modification of Acenocoumarol Anticoagulation During the Initial Treatment Period

✍ Teichert, M; van Schaik, RHN; Hofman, A; Uitterlinden, AG; de Smet, PAGM; Strick 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 701 KB

Effect of different genetics variants: C

Effect of different genetics variants: CYP2C9*2, CYP2C9*3 of cytochrome P-450 CYP2C9 and 1639G>A of the VKORC1 gene; On acenocoumarol requirement in Moroccan patients

✍ Smires, F.Z.; Habbal, R.; Moreau, C.; Assaidi, A.; Loriot, M.A.; Nadifi, S. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 264 KB

The influence of VKORC1 and CYP2C9 gene

The influence of VKORC1 and CYP2C9 gene sequence variants on the stability of maintenance phase warfarin treatment

✍ Skov, Jane; Bladbjerg, Else-Marie; Leppin, Anja; Jespersen, Jørgen 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 271 KB

PCV45 COST-EFFECTIVENESS OF CYP2C9 AND V

PCV45 COST-EFFECTIVENESS OF CYP2C9 AND VKORC1 GENOTYPE-GUIDED WARFARIN ANTICOAGULATION CARE: THE IMPLEMENTATION OF DISCRETE EVENT SIMULATION MODEL ON THE NATURAL HISTORY OF VENOUS THROMBOEMBOLISM

✍ R. Teschemaker; W. Lawrence; A.K. Wutoh 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB